Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with managing diabetes.
Our sister site, Drug Delivery Business News, reports today that the maker of the leading FreeStyle Libre continuous glucose monitor (CGM) platform launched the “Above the Bias” initiative after a new survey highlighted how everyday comments centered around food, appearances and other stigmas may affect people living with diabetes.
Abbott says survey data revealed misconceptions and stereotypes that weigh heavily on the minds of those with diabetes. These can create yet another barrier to care, potentially preventing people from managing their health.
Read a Q&A about the initiative with Guzman and Dr. Mahmood Kazemi, chief medical officer for Abbott’s Diabetes Care business HERE. People can learn about the initiative at AboveBias.com.
Get the full story at our sister site, Drug Delivery Business News.